You just read:

PTC Therapeutics Announces First Publication of Real-World Data Showing Translarna™ (ataluren) Significantly Preserves Ability to Walk for Longer in Children with Duchenne Muscular Dystrophy

News provided by

PTC Therapeutics, Inc.

Feb 03, 2020, 08:00 ET